Your browser doesn't support javascript.
loading
MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer.
Lee, Sung Hwan; Hwang, Ho Kyoung; Lee, Woo Jung; Kang, Chang Moo.
Affiliation
  • Lee SH; Department of Surgery, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
  • Hwang HK; Laboratory of HBP Integrative Precision Oncology, CHA Bio Complex, CHA Health System, Seongnam, Republic of Korea.
  • Lee WJ; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Kang CM; Pancreatobiliary Cancer Center, Yonsei Cancer Center, Severance Hospital, 50-1, Yonsei-ro, Seodaemun-gu, Seoul, Republic of Korea.
Cell Oncol (Dordr) ; 44(6): 1363-1371, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34791637

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Monocarboxylic Acid Transporters / Deoxycytidine / Molecular Targeted Therapy / Muscle Proteins Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cell Oncol (Dordr) Year: 2021 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Monocarboxylic Acid Transporters / Deoxycytidine / Molecular Targeted Therapy / Muscle Proteins Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cell Oncol (Dordr) Year: 2021 Document type: Article Country of publication: Netherlands